Risk-based Monitoring Considerations in Rare Disease Trials

In this white paper "Risk-based Monitoring Considerations in Rare Disease Trials," learn how PPD created an adaptive and intelligent monitoring strategy uniquely tailored to rare and uncommon diseases utilizing individual patient data points. PPD’s approach maintains a focus on quality and timely data using a detailed protocol risk assessment process and Preclarus®, a robust portfolio of technology solutions with real-time data.

Preclarus Risk-based Monitoring White Paper

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.